Jade Biosciences, Inc. (JBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
Jade Biosciences, Inc. (JBIO) Earnings: Report Dates and Results
Jade Biosciences (JBIO) is expected to report earnings on Mar 4, 2027. In the quarter ended Sep 30, 2026, Jade Biosciences reported EPS of -$0.42, above the -$0.73 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
JBIO has an expected report date of Mar 4, 2027.
Earnings History
Of the 20 quarters below that had an estimate, JBIO beat 3 and missed 17. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 490.24% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.42 | -$0.73 | N/A | +42.47% | Beat | N/A | 1 | 0 up, 1 down | Nov 13, 2026 |
| Jun 30, 2026 | -$0.76 | -$0.66 | N/A | -15.15% | Miss | N/A | 1 | 0 up, 0 down | Aug 10, 2026 |
| Mar 31, 2026 | -$0.57 | -$0.48 | -$0.57 - -$0.38 | -18.75% | Miss | N/A | 8 | 3 up, 2 down | May 7, 2026 |
| Sep 30, 2025 | -$0.48 | -$0.67 | N/A | +28.36% | Beat | N/A | N/A | 0 up, 0 down | Nov 13, 2025 |
| Jun 30, 2025 | -$0.86 | -$0.48 | N/A | -79.17% | Miss | N/A | N/A | 0 up, 0 down | Aug 13, 2025 |
| Mar 31, 2025 | -$12.10 | -$2.05 | N/A | -490.24% | Miss | N/A | N/A | N/A | Apr 25, 2025 |
| Dec 31, 2024 | -$6.61 | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | Mar 27, 2025 |
| Sep 30, 2024 | -$19.60 | -$20.31 | N/A | +3.48% | Beat | N/A | N/A | N/A | Nov 11, 2024 |
| Jun 30, 2024 | -$30.10 | -$29.72 | N/A | -1.28% | Miss | N/A | N/A | N/A | Aug 12, 2024 |
| Mar 31, 2024 | -$0.83 | -$0.76 | N/A | -9.21% | Miss | N/A | N/A | N/A | May 13, 2024 |
| Dec 31, 2023 | -$25.90 | -$25.87 | N/A | -0.10% | Miss | N/A | N/A | N/A | Mar 25, 2024 |
| Sep 30, 2023 | -$0.71 | -$0.69 | N/A | -2.90% | Miss | N/A | N/A | N/A | Nov 13, 2023 |
| Jun 30, 2023 | -$0.76 | -$0.70 | N/A | -8.57% | Miss | N/A | N/A | N/A | Aug 14, 2023 |
| Mar 31, 2023 | -$0.67 | -$0.57 | N/A | -17.54% | Miss | N/A | N/A | N/A | May 16, 2023 |
| Dec 31, 2022 | -$21.35 | -$21.33 | N/A | -0.10% | Miss | N/A | N/A | N/A | Mar 29, 2023 |
| Sep 30, 2022 | -$0.56 | -$0.50 | N/A | -12.00% | Miss | N/A | N/A | N/A | Nov 14, 2022 |
| Jun 30, 2022 | -$17.15 | -$17.13 | N/A | -0.10% | Miss | N/A | N/A | N/A | Aug 17, 2022 |
| Mar 31, 2022 | -$15.75 | -$15.73 | N/A | -0.10% | Miss | N/A | N/A | N/A | May 16, 2022 |
| Dec 31, 2021 | -$11.90 | -$11.54 | N/A | -3.13% | Miss | N/A | N/A | N/A | Mar 30, 2022 |
| Sep 30, 2021 | -$9.10 | -$9.09 | N/A | -0.10% | Miss | N/A | N/A | N/A | Nov 15, 2021 |
| Jun 30, 2021 | -$833.00 | -$832.17 | N/A | -0.10% | Miss | N/A | N/A | N/A | Aug 16, 2021 |
| Mar 31, 2021 | -$12.77 | -$0.62 | N/A | N/A | N/A | N/A | N/A | N/A | May 6, 2021 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$13.44, after -$57.14 the year before. It was -$866.77 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$13.44 | N/A |
| Dec 31, 2024 | -$57.14 | N/A |
| Dec 31, 2023 | -$28.04 | N/A |
| Dec 31, 2022 | -$54.81 | N/A |
| Dec 31, 2021 | -$866.77 | N/A |
Frequently Asked Questions About JBIO
When is Jade Biosciences's next earnings date?
Jade Biosciences's next earnings report is expected for Mar 4, 2027.
Did JBIO beat earnings estimates last quarter?
Yes. Jade Biosciences reported EPS of -$0.42 for the quarter ended Sep 30, 2026, above the -$0.73 estimate, a 42.47% surprise.
What EPS do analysts expect from JBIO next quarter?
The consensus EPS estimate for Jade Biosciences for the quarter ending Dec 31, 2026 is -$0.74 from 12 analysts, with estimates from -$0.88 to -$0.55.
How often does JBIO beat earnings estimates?
Jade Biosciences beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -66.29%.
JBIO pages: Overview, Earnings, Forecast, Financials, Competitors